Dr. Swier primarily studies methods to relieve nerve compression in patients with diabetic neuropathy, a condition where nerve damage affects foot health. His research includes techniques like tibial neurolysis, aimed at preventing severe complications such as ulcers and amputations for diabetic patients. Additionally, Dr. Swier explores the anatomy of nerves relevant to surgical procedures, as well as techniques and devices that aid in heart and vascular treatments, ensuring patient safety and improved recovery outcomes.
Key findings
In a study of 628 patients undergoing decompression for chronic tibial nerve compression, pain scores improved significantly from 8.5 to 2.0 within six months post-surgery, with lasting effects for over three years.
In a multicenter trial of tibial neurolysis for diabetic neuropathy patients, only 0.2% developed new ulcers, and only one limb experienced amputation, highlighting the procedure's effectiveness in avoiding serious complications.
His research on anatomical variations in the common peroneal nerve showed that 78.5% of patients had a fibrous band that can complicate surgeries, differing from 30% in cadaver studies, indicating the need for tailored surgical approaches.
Frequently asked questions
Does Dr. Swier study diabetic neuropathy?
Yes, Dr. Swier researches treatments for diabetic neuropathy, focusing on alleviating nerve compression and preventing complications like ulcers and amputations.
What treatments has Dr. Swier developed or researched?
Dr. Swier has developed and researched surgical techniques like tibial neurolysis to relieve nerve compression in diabetic patients, leading to significant pain relief and preventing critical foot problems.
Is Dr. Swier's work relevant to patients with heart conditions?
Yes, his studies also cover cardiovascular treatments, focusing on improving device safety and effectiveness, which is directly relevant to patients needing heart surgery or devices.
Publications in plain English
Prevention of ulceration, amputation, and reduction of hospitalization: outcomes of a prospective multicenter trial of tibial neurolysis in patients with diabetic neuropathy.
2012
Journal of reconstructive microsurgery
Dellon AL, Muse VL, Nickerson DS, Akre T, Anderson SR +35 more
Plain English This study looked at a procedure called tibial neurolysis, which helps people with diabetes who have nerve problems in their legs. Out of 628 patients treated, only 0.2% developed new ulcers and another 0.2% faced amputations, while hospital admissions for foot infections were just 0.6%. This is important because it shows that this treatment can significantly reduce the risk of serious foot problems in diabetic patients.
Who this helps: This benefits patients with diabetes and diabetic neuropathy.
A positive Tinel sign as predictor of pain relief or sensory recovery after decompression of chronic tibial nerve compression in patients with diabetic neuropathy.
2012
Journal of reconstructive microsurgery
Dellon AL, Muse VL, Scott ND, Akre T, Anderson SR +35 more
Plain English This study looked at how a positive Tinel sign, which is a response felt when tapping over a nerve, can predict recovery from pain and improved sensation in diabetic patients with nerve compression in their feet. Researchers followed 628 patients, finding that 74% had high pain levels ahead of surgery. After procedures to relieve the nerve compression, patients saw their average pain drop from 8.5 to 2.0 within six months, and this improvement lasted for over three years.
Who this helps: This benefits diabetic patients suffering from nerve pain in their feet.
Anatomic variations related to decompression of the common peroneal nerve at the fibular head.
2002
Annals of plastic surgery
Dellon AL, Ebmer J, Swier P
Plain English This study looked at variations in the anatomy of the peroneal nerve and its related muscles during surgeries designed to relieve pressure on the nerve, especially in diabetic patients. Researchers found that a particular fibrous band that can affect surgery was present in 78.5% of patients but only in 30% of cadavers, which highlights a significant difference. Understanding these variations, like the fibrous bands found in 30% to 78.5% of cases, is crucial for surgeons to perform safe and effective procedures.
Who this helps: This helps patients undergoing surgery for nerve compression, particularly those with diabetic foot issues.
Converting to digital photography: a model for a large group or academic practice.
2000
Plastic and reconstructive surgery
Galdino GM, Swier P, Manson PN, Vander Kolk CA
Plain English This study focused on switching from traditional photography to digital photography in a clinical setting to save costs and simplify storage. Over three years, they analyzed the expenses of both types of photography and found that moving to digital could lead to significant savings in the long run. The transition not only cuts costs but also improves efficiency in managing patient images, which is important for medical practices.
Who this helps: This benefits doctors and healthcare facilities looking for cost-effective solutions to manage patient images.
Long-segment substernal jejunal esophageal replacement with internal mammary vascular augmentation.
2000
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Heitmiller RF, Gruber PJ, Swier P, Singh N
Plain English This study focuses on a new surgical method that improves blood flow to the portion of the intestine used to replace the esophagus. By using the internal mammary vessels for added support, researchers found that this approach helps the graft get more blood, reducing the risk of complications. Improved blood supply is important because it helps ensure the success of the transplant.
Who this helps: This benefits patients undergoing esophageal replacement surgery.
Cardiac output and mixed venous O2 content measurements by a tracer bolus method: animal validation study.
1998
Journal of applied physiology (Bethesda, Md. : 1985)
Clark JS, Lin YJ, Criddle MJ, Jones R, Koppert E +1 more
Plain English Researchers tested a new, noninvasive method to measure heart output and oxygen levels in the blood using a special technique called the bolus method on 18 dogs. They found that this new method produced heart output results very close to the standard method, with differences of less than 0.08 liters per minute when averaged over ten minutes. This is important because it shows the bolus method can accurately track heart output even in unstable patients who may need quick adjustments.
Who this helps: This benefits doctors who monitor heart function in patients.
Cardiac output requirements and maximum dimensions for a neonate total artificial heart.
1991
The International journal of artificial organs
Koppert E, Pantalos GM, Tieleman R, Swier P, Burns GL
Plain English This study focused on creating a total artificial heart (TAH) for newborns by determining how big it should be and how much blood it needs to pump. Researchers examined 12 hearts from babies with a serious heart condition to figure out the largest size for the artificial heart and analyzed data on blood flow requirements from healthy and sick newborns. They found specific size and blood pumping requirements that can guide the design of a new TAH, which is important for improving care for affected infants.
Who this helps: This helps infants needing heart surgery and the doctors who treat them.
Detection of microemboli by constant-pressure filtration during in vitro circulation of bovine and human blood.
1990
Artificial organs
Solen KA, Mohammad SF, Pijl AJ, Swier P, Monson RD +1 more
Plain English This study examined how a new method called constant-pressure filtration (CPF) can detect tiny blood clots, known as microemboli, in both cow and human blood. Researchers found that as blood was pumped, the concentration of microemboli increased, while a test for blood thinning showed a decrease in time, indicating more active clotting. Specifically, the blood from the pumping control group had higher microemboli levels compared to blood treated with aspirin and the non-pumping control group, showing how different conditions can affect blood flow.
Who this helps: This research benefits doctors and medical researchers looking to improve treatments for blood clotting issues in patients.
A comparison of the antiplatelet effect of aspirin on human and bovine platelets.
1989
ASAIO transactions
Swier P, Mohammad SF, Olsen DB, Kolff WJ
Plain English This study compared how aspirin affects the blood cells that help clotting, known as platelets, in humans and cows (bovine). Researchers found that aspirin significantly reduced platelet activity in humans starting at doses of 80 mg in lab tests and 2,500 mg when taken as a pill. In contrast, even high doses of aspirin (up to 4,000 mg) did not seem to affect cow platelets at all. Understanding these differences is important because it helps researchers choose the right animal models when testing treatments for blood clotting issues that might affect both humans and animals.
Who this helps: This information benefits researchers and veterinarians studying blood-thinning treatments in both humans and animals.
New polyurethane valves in new soft artificial hearts.
1989
ASAIO transactions
Yu LS, Yuan B, Bishop D, Topaz S, van Griensven J +5 more
Plain English This study looked at new types of valves and a soft artificial heart designed to be easier to implant. Researchers found that five polyurethane valves implanted in sheep remained intact for over a year, and when tested in calves, the new soft artificial heart with bistable valves showed fewer blood clots, particularly in the kidneys, than previous designs, which is a big improvement. This matters because reducing blood clots can lead to better outcomes in patients receiving artificial hearts.
Who this helps: This benefits patients needing heart replacements and the doctors who treat them.
Characterization of blood microemboli associated with ex vivo left ventricular assist devices in a bovine model.
1989
ASAIO transactions
Solen KA, Mohammad SF, Reynolds LO, Pantalos GM, Swier P +3 more
Plain English In this study, researchers used calves to investigate how blood clots (microemboli) form when using a left ventricular assist device (LVAD), a device that helps pump blood. They found that one particular ventricle produced significantly more blood clots than the others, with key measurements indicating higher levels of coagulation markers and clot sizes over time. These findings are important because they can help improve the design and application of LVADs, making them safer and more effective for patients with heart issues.
Who this helps: Patients with severe heart conditions who may need an LVAD.
An in vitro test model to study the performance and thrombogenicity of cardiovascular devices.
1989
ASAIO transactions
Swier P, Bos WJ, Mohammad SF, Olsen DB, Kolff WJ
Plain English This study created a lab test to evaluate how well cardiovascular devices work and how likely they are to cause blood clotting. It used a setup that mimicked the conditions of the human heart with about 1.4 liters of blood and monitored various blood measures for 2-3 hours. The researchers tested different types of valves and devices, helping to ensure safer and more effective heart treatments.
Who this helps: This helps patients needing cardiovascular devices and their doctors.